SCHEMBL5663166

SCHEMBL5663166

Cc1ccc(NCCC(C)N2CC3CN(C(=O)c4c(C)cc(=O)[nH]c4C)CC3C2)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.38
MAPT P10636 5/20 0.37
ALDH1A1 P00352 3/20 0.37
AADAT Q8N5Z0 1/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 2/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
LMNA P02545 1/20 0.35
USP2 O75604 1/20 0.35
TSHR P16473 1/20 0.35
HRH4 Q9H3N8 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4697510 0.87 CCR5 (0.46) CCR5L3MBTL1MAPTALDH1A1AADAT
SCHEMBL5659108 0.85 CCR5 (0.53) CCR5L3MBTL1MAPTALDH1A1TP53
SCHEMBL3283576 0.81 CCR5 (0.44) CCR5L3MBTL1MAPTALDH1A1HCRTR1
SCHEMBL4701550 0.80 CCR5 (0.53) CCR5MAPTALDH1A1TP53POLB
SCHEMBL13359864 0.77 ALDH1A1 (0.40) L3MBTL1MAPTALDH1A1HTTSMN1; SMN2
SCHEMBL5659102 0.76 CCR5 (0.45) CCR5POLBHCRTR1HCRTR2HRH4
SCHEMBL14440824 0.76 CCR5 (0.46) CCR5
SCHEMBL5663163 0.75 CCR5 (0.42) CCR5ALDH1A1POLBHCRTR1HCRTR2
SCHEMBL4692659 0.71 MAPT (0.42) CCR5L3MBTL1MAPTALDH1A1TP53
SCHEMBL4694337 0.71 CCR5 (0.43) CCR5L3MBTL1MAPTALDH1A1HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070191335-A1 4-{2-[5-(4,6-Dimethyl-pyrimidine-5-carbonyl)-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl]-ethyl}-4-phenyl-piperidine-1-carboxylic acid tert-butyl ester,chemokine receptor antagonist; human immunodeficiency virus (HIV) infection, AIDS or ARC, antiinflammatory agent, autoimmune diseases, graft v. host disease ROCHE PALO ALTO LLC 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191335-A1 4-{2-[5-(4,6-Dimethyl-pyrimidine-5-carbonyl)-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl]-ethyl}-4-phenyl-piperidine-1-carboxylic acid tert-butyl ester,chemokine receptor antagonist; human immunodeficiency virus (HIV) infection, AIDS or ARC, antiinflammatory agent, autoimmune diseases, graft v. host disease CCR5, CXCR1, CXCR3 CCR5 1/4885L3MBTL1 3377/4885MAPT 3482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.